CHTR vs COLL · P/E 11, rev $55.09B vs P/E 17, rev $181.9M
Charter Communications Inc (CHTR) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CHTR revenue for 2024-12-31 was $55.09B. Net income was $5.85B. Revenue was up 0.9% from 2023-12-31 to 2024-12-31. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CHTR currently screens at market cap $56.24B and trailing P/E 11.5. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CHTR and COLL stock pages for the full models.
Not investment advice.